Characterization of within-subject responses to fluticasone and montelukast in childhood asthma - Szefler, Stanley J.; Phillips, Brenda R.; Martinez, Fernando D.; Chinchilli, Vernon M.; Lemanske, Robert F.; Strunk, Robert C.; Zeiger, Robert S.; Larsen, Gary; Spahn, Joseph D.; Bacharier, Leonard B.; Bloomberg, Gordon R.; Guilbert, Theresa W.; et al. (Journal of allergy and clinical immunology, 2005)
Keywords: Acetates - administration & dosage; Acetates - therapeutic use; Administration, Inhalation; Adolescent; Androstadienes - administration & dosage; Androstadienes - therapeutic use; Anti-Asthmatic Agents - administration & dosage; Anti-Asthmatic Agents - therapeutic use; Asthma; Asthma - blood; Asthma - drug therapy; Asthma - physiopathology; Biological and medical sciences; biomarkers; Bronchodilator Agents - administration & dosage; Bronchodilator Agents - therapeutic use; Child; Cross-Over Studies; Double-Blind Method; Eosinophil Cationic Protein - blood; Eosinophils - pathology; Exhalation; exhaled nitric oxide; Female; Fluticasone; fluticasone propionate; Forced Expiratory Volume; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Humans; Immunoglobulin E - metabolism; Immunopathology; inhaled corticosteroids; Leukocyte Count; Male; Medical sciences; montelukast; Nitric Oxide; Predictive Value of Tests; pulmonary response; Quinolines - administration & dosage; Quinolines - therapeutic use; Vital Capacity; uLTE 4; biomarkers; eNO; eDEM; Asthma; FVC; ECP; TEC; LTRA; montelukast; fluticasone propionate; exhaled nitric oxide; ICS; pulmonary response; inhaled corticosteroids; Leukotriene receptor; Biological marker; Montelukast; Leukotriene D4; Fluticasone; Antiasthma agent; Respiratory system; Immunology; Eicosanoid; Leukotriene antagonist; Bronchus disease; Obstructive pulmonary disease; Child; Human; Immunopathology; Lung disease; Corticosteroid; Respiratory disease; Arachidonic acid derivatives; Antiinflammatory agent; Leukotriene E4; Inhalation; Nitric oxide